The alpha 4 beta 1 fibronectin ligands CS-1, HEP II, and RGD induce different intracellular events in B lymphoid cells. Comparison with the effects of the endothelial ligand VCAM-1

被引:16
作者
DominguezJimenez, C [1 ]
SanchezAparicio, P [1 ]
Albar, JP [1 ]
GarciaPardo, A [1 ]
机构
[1] CSIC,CTR NACL BIOTECNOL,DEPT INMUNOL,MADRID 28049,SPAIN
关键词
B lymphocytes; alpha; 4; beta; 1; integrin; cell signaling; fibronectin; cytoskeleton;
D O I
10.3109/15419069609010770
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The lymphocyte integrin alpha 4 beta 1 is the receptor for the Hep II domain and CS-1 site in fibronectin (Fn) as well as for VCAM-1. We recently showed that upon activation with anti-beta 1 mAb TS2/16, alpha 4 beta 1 also recognizes the RGD Fn sequence. To determine the physiological role of these multiple interactions, we have now studied some intracellular events induced by ''resting'' and activated alpha 4 beta 1 binding to its different ligands. Analyses of actin and tubulin reorganization upon adhesion of B lymphoid cells to Fn fragments or VCAM-1 showed that VCAM-1, a 38 kDa fragment (Hep II+CS-1), and the CS-1 synthetic peptide induced formation of transient cytoplasmic projections; however, cells attached to a 58 kDa (Hep II) or 80 kDa (RGD) fragments remained rounded. Using transfilter assays, we showed that VCAM-1, 38 kDa and CS-1 also induced dose-dependent B cell migration mediated by alpha 4 beta 1. Furthermore, these three ligands, but not the 80 kDa fragment or a synthetic peptide (H1) containing a sequence from Hep II shown to bind alpha 4 beta 1, induced tyrosine phosphorylation of a 110 kDa protein. Activation of alpha 4 beta 1 with TS2/16 inhibited the cytoplasmic protrusions and cell migration but did not affect the pattern of phosphorylation. Our results indicate that the various alpha 4 beta 1 ligands induce different cellular responses. Most importantly they show that alpha 4 beta 1 interaction with CS-1 is sufficient to trigger intracellular events in B cells. Furthermore, they suggest a regulation by the activation form of the receptor as well as by the ligand in events involving lymphocyte adhesion and migration.
引用
收藏
页码:251 / &
页数:19
相关论文
共 44 条
  • [1] THE INTEGRIN VLA-4 SUPPORTS TETHERING AND ROLLING IN FLOW ON VCAM-1
    ALON, R
    KASSNER, PD
    CARR, MW
    FINGER, EB
    HEMLER, ME
    SPRINGER, TA
    [J]. JOURNAL OF CELL BIOLOGY, 1995, 128 (06) : 1243 - 1253
  • [2] ALPHA-4 INTEGRINS MEDIATE LYMPHOCYTE ATTACHMENT AND ROLLING UNDER PHYSIOLOGICAL FLOW
    BERLIN, C
    BARGATZE, RF
    CAMPBELL, JJ
    VONANDRIAN, UH
    SZABO, MC
    HASSLEN, SR
    NELSON, RD
    BERG, EL
    ERLANDSEN, SL
    BUTCHER, EC
    [J]. CELL, 1995, 80 (03) : 413 - 422
  • [3] BERSHADSKY AD, 1988, CYTOSKELETON, P217
  • [4] BOCKHOLT SM, 1993, J BIOL CHEM, V268, P14565
  • [5] TYROSINE PHOSPHORYLATION OF PAXILLIN AND PP125(FAK) ACCOMPANIES CELL-ADHESION TO EXTRACELLULAR-MATRIX - A ROLE IN CYTOSKELETAL ASSEMBLY
    BURRIDGE, K
    TURNER, CE
    ROMER, LH
    [J]. JOURNAL OF CELL BIOLOGY, 1992, 119 (04) : 893 - 903
  • [6] DISTINCT CELLULAR FUNCTIONS MEDIATED BY DIFFERENT VLA INTEGRIN ALPHA-SUBUNIT CYTOPLASMIC DOMAINS
    CHAN, BM
    KASSNER, PD
    SCHIRO, JA
    BYERS, HR
    KUPPER, TS
    HEMLER, ME
    [J]. CELL, 1992, 68 (06) : 1051 - 1060
  • [7] CHAN PY, 1993, J BIOL CHEM, V268, P24655
  • [8] INTEGRINS AND SIGNAL-TRANSDUCTION PATHWAYS - THE ROAD TAKEN
    CLARK, EA
    BRUGGE, JS
    [J]. SCIENCE, 1995, 268 (5208) : 233 - 239
  • [9] ATTACHMENT, SPREADING AND LOCOMOTION OF AVIAN NEURAL CREST CELLS ARE MEDIATED BY MULTIPLE ADHESION SITES ON FIBRONECTIN MOLECULES
    DUFOUR, S
    DUBAND, JL
    HUMPHRIES, MJ
    OBARA, M
    YAMADA, KM
    THIERY, JP
    [J]. EMBO JOURNAL, 1988, 7 (09) : 2661 - 2671
  • [10] EXPRESSION AND FUNCTIONAL-SIGNIFICANCE OF ALTERNATIVELY SPLICED CS1 FIBRONECTIN IN RHEUMATOID-ARTHRITIS MICROVASCULATURE
    ELICES, MJ
    TSAI, V
    STRAHL, D
    GOEL, AS
    TOLLEFSON, V
    ARRHENIUS, T
    WAYNER, EA
    GAETA, FCA
    FIKES, JD
    FIRESTEIN, GS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) : 405 - 416